Success Story: A Pulmonologist/Intensivist Secures EB-2 NIW Approval With Our Guidance
Client’s Testimonial:
"Thank you so much for all your help!!"
On April 30th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Pulmonologist/Intensivist in the Field of Clinical Medicine (Approval Notice).
General Field: Clinical Medicine
Position at the Time of Case Filing: Pulmonologist/Intensivist
Approval Notice Date: April 30th, 2026
Processing Time: 6 months, 21 days
Case Summary:
It was a privilege for our team to assist a pulmonologist and intensivist in the field of clinical medicine with an EB-2 NIW petition. This case reflects our commitment to I-140 clients through strategic, case-by-case analysis and meticulous petition development, resulting in approval in just over 6 months.
Building the Foundation
Holding an M.B.B.S. with specialized expertise in pulmonary medicine, critical care, and sleep medicine, the petitioner actively contributes to medical education and clinical training in these specialties.
Our team's initial assessment identified several compelling strengths across the petitioner's academic and professional background. We strategically built the case around a well-documented research focus that directly aligns with pressing U.S. public health priorities, demonstrating how the work addresses critical national needs with both substantial merit and broad societal impact.
Demonstrated Achievements
The petition documented key metrics: 200 citations, 5 peer-reviewed journal articles, and 14 abstracts (9 of them first-authored). The petitioner has also completed 1 peer review, reflecting the academic community's recognition as a trusted expert evaluator. We further highlighted notable citations from researchers who directly built upon these findings, spanning antibiotic resistance, respiratory toxicology, and pulmonary imaging diagnostics, illustrating the real-world reach and influence of the work.
NIW Approval and Outlook
This outcome underscores our continued success in securing approvals for medical professionals whose work bridges clinical practice and research to advance public health. The ongoing research into advanced therapeutic interventions as a treatment for debilitating conditions continues to drive meaningful progress toward improved patient care standards and reduced chronic illness burdens, aligning closely with long-term national goals of innovation, resilience, and population health leadership.